We found that BL‐19 effectively prevented rapid weight gain in NAFLD mice and reduced their overall food and energy intake, decreased liver inflammatory factors expressions, and increased the bile acid synthetase enzyme CYP7A1 and superoxide dismutase. The gene discussed is CYP7A1; the disease is metabolic dysfunction-associated steatotic liver disease.